• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种多菌株益生菌配方通过调节紧密连接和黏附连接蛋白改善肠道屏障功能。

A Multi-Strain Probiotic Formulation Improves Intestinal Barrier Function by the Modulation of Tight and Adherent Junction Proteins.

机构信息

Department of Pharmaceutical Sciences, University of Perugia, Via Romana, 06126 Perugia, Italy.

出版信息

Cells. 2022 Aug 22;11(16):2617. doi: 10.3390/cells11162617.

DOI:10.3390/cells11162617
PMID:36010692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9406415/
Abstract

In healthy individuals, tight junction proteins (TJPs) maintain the integrity of the intestinal barrier. Dysbiosis and increased intestinal permeability are observed in several diseases, such as inflammatory bowel disease. Many studies highlight the role of probiotics in preventing intestinal barrier dysfunction. The present study aims to investigate the effects of a commercially available probiotic formulation of LR 32, BL 04, and BB 536 (Serobioma, Bromatech s.r.l., Milan, Italy) on TJPs and the integrity of the intestinal epithelial barrier, and the ability of this formulation to prevent lipopolysaccharide-induced, inflammation-associated damage. An in vitro model of the intestinal barrier was developed using a Caco-2 cell monolayer. The mRNA expression levels of the TJ genes were analyzed using real-time PCR. Changes in the amounts of proteins were assessed with Western blotting. The effect of Serobioma on the intestinal epithelial barrier function was assessed using transepithelial electrical resistance (TEER) measurements. The probiotic formulation tested in this study modulates the expression of TJPs and prevents inflammatory damage. Our findings provide new insights into the mechanisms by which probiotics are able to prevent damage to the gut epithelial barrier.

摘要

在健康个体中,紧密连接蛋白(TJPs)维持肠道屏障的完整性。在几种疾病中,如炎症性肠病,观察到肠道菌群失调和肠道通透性增加。许多研究强调了益生菌在预防肠道屏障功能障碍中的作用。本研究旨在研究一种市售益生菌制剂 LR 32、BL 04 和 BB 536(Serobioma,Bromatech s.r.l.,米兰,意大利)对 TJPs 和肠道上皮屏障完整性的影响,以及该制剂预防脂多糖诱导的炎症相关损伤的能力。使用 Caco-2 细胞单层建立了肠道屏障的体外模型。使用实时 PCR 分析 TJ 基因的 mRNA 表达水平。使用 Western blotting 评估蛋白质含量的变化。使用跨上皮电阻(TEER)测量来评估 Serobioma 对肠道上皮屏障功能的影响。本研究中测试的益生菌制剂调节 TJPs 的表达并预防炎症损伤。我们的研究结果提供了关于益生菌能够预防肠道上皮屏障损伤的机制的新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/9406415/0f12db7ffa62/cells-11-02617-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/9406415/eebd2e95f75b/cells-11-02617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/9406415/6934d3c1979e/cells-11-02617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/9406415/52ae493bc357/cells-11-02617-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/9406415/0f12db7ffa62/cells-11-02617-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/9406415/eebd2e95f75b/cells-11-02617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/9406415/6934d3c1979e/cells-11-02617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/9406415/52ae493bc357/cells-11-02617-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/9406415/0f12db7ffa62/cells-11-02617-g004.jpg

相似文献

1
A Multi-Strain Probiotic Formulation Improves Intestinal Barrier Function by the Modulation of Tight and Adherent Junction Proteins.一种多菌株益生菌配方通过调节紧密连接和黏附连接蛋白改善肠道屏障功能。
Cells. 2022 Aug 22;11(16):2617. doi: 10.3390/cells11162617.
2
Consumption of honey ameliorates lipopolysaccharide-induced intestinal barrier dysfunction via upregulation of tight junction proteins.蜂蜜的摄入可通过上调紧密连接蛋白来改善脂多糖诱导的肠道屏障功能障碍。
Eur J Nutr. 2023 Oct;62(7):3033-3054. doi: 10.1007/s00394-023-03203-y. Epub 2023 Jul 26.
3
Schisandrin C improves leaky gut conditions in intestinal cell monolayer, organoid, and nematode models by increasing tight junction protein expression.五味子丙素通过增加紧密连接蛋白的表达改善肠细胞单层、类器官和线虫模型中的肠漏状况。
Phytomedicine. 2022 Aug;103:154209. doi: 10.1016/j.phymed.2022.154209. Epub 2022 May 27.
4
Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions.酸奶通过增加紧密连接抑制 Caco-2 细胞的肠道屏障功能障碍。
Food Funct. 2017 Jan 25;8(1):406-414. doi: 10.1039/c6fo01592a.
5
Combined probiotic bacteria promotes intestinal epithelial barrier function in interleukin-10-gene-deficient mice.联合益生菌可促进白细胞介素-10基因缺陷小鼠的肠道上皮屏障功能。
World J Gastroenterol. 2014 Apr 28;20(16):4636-47. doi: 10.3748/wjg.v20.i16.4636.
6
Indigenous lactobacilli strains of food and human sources reverse enteropathogenic E. coli O26:H11-induced damage in intestinal epithelial cell lines: effect on redistribution of tight junction proteins.来自食物和人类源的本土乳酸杆菌菌株可逆转肠致病性大肠杆菌O26:H11诱导的肠道上皮细胞系损伤:对紧密连接蛋白重新分布的影响。
Microbiology (Reading). 2017 Sep;163(9):1263-1272. doi: 10.1099/mic.0.000507. Epub 2017 Aug 4.
7
Akkermansia muciniphila improves heat stress-impaired intestinal barrier function by modulating HSP27 in Caco-2 cells.嗜黏蛋白阿克曼氏菌通过调节Caco-2细胞中的HSP27改善热应激受损的肠道屏障功能。
Microb Pathog. 2023 Apr;177:106028. doi: 10.1016/j.micpath.2023.106028. Epub 2023 Feb 14.
8
Multi-Species Probiotic Strain Mixture Enhances Intestinal Barrier Function by Regulating Inflammation and Tight Junctions in Lipopolysaccharides Stimulated Caco-2 Cells.多物种益生菌菌株混合物通过调节脂多糖刺激的Caco-2细胞中的炎症和紧密连接来增强肠道屏障功能。
Microorganisms. 2023 Mar 3;11(3):656. doi: 10.3390/microorganisms11030656.
9
Bifidobacterium dentium N8 with potential probiotic characteristics prevents LPS-induced intestinal barrier injury by alleviating the inflammatory response and regulating the tight junction in Caco-2 cell monolayers.具有潜在益生菌特性的齿双歧杆菌 N8 通过减轻炎症反应和调节 Caco-2 细胞单层中的紧密连接来预防 LPS 诱导的肠道屏障损伤。
Food Funct. 2021 Aug 21;12(16):7171-7184. doi: 10.1039/d1fo01164b. Epub 2021 Jul 16.
10
Prophylactic Treatment of Probiotic and Metformin Mitigates Ethanol-Induced Intestinal Barrier Injury: , , and Approaches.益生菌和二甲双胍预防治疗减轻乙醇诱导的肠道屏障损伤: 、 和 方法。
Mediators Inflamm. 2021 Sep 27;2021:5245197. doi: 10.1155/2021/5245197. eCollection 2021.

引用本文的文献

1
Probiotics in inflammatory bowel diseases: emphasis on mechanisms and clinical application.炎症性肠病中的益生菌:着重于作用机制及临床应用
Front Med (Lausanne). 2025 Aug 1;12:1620079. doi: 10.3389/fmed.2025.1620079. eCollection 2025.
2
A multi-strain probiotic formulation preserves intestinal epithelial and vascular barriers during enteropathogenic infection.一种多菌株益生菌制剂在肠道致病性感染期间可维持肠道上皮和血管屏障。
Front Microbiol. 2025 Jul 25;16:1631322. doi: 10.3389/fmicb.2025.1631322. eCollection 2025.
3
Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome.

本文引用的文献

1
Gut health benefit and application of postbiotics in animal production.后生元对肠道健康的益处及其在动物生产中的应用。
J Anim Sci Biotechnol. 2022 Apr 8;13(1):38. doi: 10.1186/s40104-022-00688-1.
2
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases.肠道屏障功能障碍在肠道菌群失调和疾病中的影响
Biomedicines. 2022 Jan 27;10(2):289. doi: 10.3390/biomedicines10020289.
3
Probiotics Supplementation Improves Intestinal Permeability, Obesity Index and Metabolic Biomarkers in Elderly Thai Subjects: A Randomized Controlled Trial.
解析代谢综合征中饮食诱导的肥胖和糖脂功能障碍的复杂性。
Diabetol Metab Syndr. 2025 Jul 22;17(1):292. doi: 10.1186/s13098-025-01837-y.
4
The impact of infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis.感染与根除疗法对肠道微生物群的影响:微生物失调及其在胃癌发生中的意义的系统评价
Front Cell Infect Microbiol. 2025 Jul 7;15:1592977. doi: 10.3389/fcimb.2025.1592977. eCollection 2025.
5
Potential Role of Probiotic Strain in Control of Histamine Metabolism.益生菌菌株在组胺代谢控制中的潜在作用。
Biology (Basel). 2025 Jun 19;14(6):734. doi: 10.3390/biology14060734.
6
The Mystery of Certain Strains in the Treatment of Gastrointestinal Symptoms of COVID-19: A Review.新冠病毒感染胃肠道症状治疗中某些毒株的奥秘:综述
Microorganisms. 2025 Apr 19;13(4):944. doi: 10.3390/microorganisms13040944.
7
A Probiotic Mixture of LR 32, BL 04, and BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1.由LR 32、BL 04和BB 536组成的益生菌混合物通过作用于紧密连接蛋白1来对抗肠易激综合征黏膜介质诱导的通透性增加。
Int J Mol Sci. 2025 Mar 15;26(6):2656. doi: 10.3390/ijms26062656.
8
An In Vitro Cell Model of Intestinal Barrier Function Using a Low-Cost 3D-Printed Transwell Device and Paper-Based Cell Membrane.一种使用低成本3D打印Transwell装置和纸质细胞膜构建的肠道屏障功能体外细胞模型。
Int J Mol Sci. 2025 Mar 12;26(6):2524. doi: 10.3390/ijms26062524.
9
Intestinal luminal anion transporters and their interplay with gut microbiome and inflammation.肠道腔阴离子转运体及其与肠道微生物群和炎症的相互作用。
Am J Physiol Cell Physiol. 2025 May 1;328(5):C1455-C1472. doi: 10.1152/ajpcell.00026.2025. Epub 2025 Mar 6.
10
Atopic Dermatitis and Atopic Keratoconjunctivitis: New Insights in the Analyses of Microbiota and Probiotic Effect.特应性皮炎和特应性角结膜炎:微生物群分析及益生菌作用的新见解
Int J Mol Sci. 2025 Feb 10;26(4):1463. doi: 10.3390/ijms26041463.
补充益生菌可改善泰国老年受试者的肠道通透性、肥胖指数和代谢生物标志物:一项随机对照试验。
Foods. 2022 Jan 19;11(3):268. doi: 10.3390/foods11030268.
4
Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier Function.益生菌、益生元和上皮紧密连接:调节肠道屏障功能的有前途的方法。
Int J Mol Sci. 2021 Jun 23;22(13):6729. doi: 10.3390/ijms22136729.
5
Gut Dysbiosis and Western Diet in the Pathogenesis of Essential Arterial Hypertension: A Narrative Review.肠道菌群失调与西方饮食在原发性高血压发病机制中的作用:叙述性综述。
Nutrients. 2021 Apr 1;13(4):1162. doi: 10.3390/nu13041162.
6
Gut dysbiosis in Huntington's disease: associations among gut microbiota, cognitive performance and clinical outcomes.亨廷顿舞蹈病中的肠道菌群失调:肠道微生物群、认知表现和临床结果之间的关联。
Brain Commun. 2020 Jul 24;2(2):fcaa110. doi: 10.1093/braincomms/fcaa110. eCollection 2020.
7
Changes in the Gut Microbiota of Children with Autism Spectrum Disorder.自闭症谱系障碍儿童肠道微生物组的变化。
Autism Res. 2020 Sep;13(9):1614-1625. doi: 10.1002/aur.2358. Epub 2020 Aug 24.
8
Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study.痴呆症中的菌群失调、肠道屏障功能障碍和炎症:一项初步研究。
BMC Geriatr. 2020 Jul 20;20(1):248. doi: 10.1186/s12877-020-01644-2.
9
Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.肠通透性、微生物易位、十二指肠和粪便微生物群的变化及其与人类酒精性肝病进展的关系。
Gut Microbes. 2020 Nov 9;12(1):1782157. doi: 10.1080/19490976.2020.1782157. Epub 2020 Jun 26.
10
Manipulation of epithelial integrity and mucosal immunity by host and microbiota-derived metabolites.宿主和微生物衍生代谢物对上皮完整性和黏膜免疫的调控。
Eur J Immunol. 2020 Jul;50(7):921-931. doi: 10.1002/eji.201948478. Epub 2020 Jun 28.